Jürgen Debus

Title: Jürgen Debus: Innovator in Protein Oligomer Research

Introduction

Jürgen Debus is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of methods for treating diseases related to angiogenesis, fibrosis, and cancer. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

Debus's latest patents include innovative methods for producing protein oligomers that can be used in the treatment of serious health conditions. One of his notable inventions is a method for producing a protein oligomer comprising at least two, and preferably three heterodimeric human NC-1-Fc proteins. This method involves culturing a host cell that expresses specific fusion proteins, allowing for the formation of the desired protein oligomer. Another significant patent focuses on a protein oligomer that can be used for treating, ameliorating, or preventing fibrosis or fibrosis-associated diseases, as well as diseases related to vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs).

Career Highlights

Throughout his career, Jürgen Debus has worked with esteemed organizations such as the Deutsches Krebsforschungszentrum and Heidelberg Biotech GmbH. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Debus has collaborated with notable colleagues, including Amir Abdollahi and Kashi Javaherian. These partnerships have further enriched his research endeavors and have led to significant advancements in his field.

Conclusion

Jürgen Debus is a distinguished inventor whose work in protein oligomer research holds promise for the treatment of various diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.